| Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling BS Moon, WJ Jeong, J Park, TI Kim, DS Min, KY Choi Journal of the National Cancer Institute 106 (2), djt373, 2014 | 190 | 2014 |
| Lysosome-rich enterocytes mediate protein absorption in the vertebrate gut J Park, DS Levic, KD Sumigray, J Bagwell, O Eroglu, CL Block, C Eroglu, ... Developmental cell 51 (1), 7-20. e6, 2019 | 75 | 2019 |
| A sensitized screen for genes promoting invadopodia function in vivo: CDC-42 and Rab GDI-1 direct distinct aspects of invadopodia formation LL Lohmer, MR Clay, KM Naegeli, Q Chi, JW Ziel, EJ Hagedorn, JE Park, ... PLoS genetics 12 (1), e1005786, 2016 | 52 | 2016 |
| A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab SK Lee, YH Cho, PH Cha, JS Yoon, EJ Ro, WJ Jeong, J Park, H Kim, ... Experimental & molecular medicine 50 (11), 1-12, 2018 | 28 | 2018 |
| A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer J Park, YH Cho, WJ Shin, SK Lee, JH Lee, T Kim, PH Cha, JS Yang, ... Scientific reports 9 (1), 648, 2019 | 26 | 2019 |
| Redundant Trojan horse and endothelial-circulatory mechanisms for host-mediated spread of Candida albicans yeast AK Scherer, BA Blair, J Park, BG Seman, JB Kelley, RT Wheeler PLoS Pathogens 16 (8), e1008414, 2020 | 18 | 2020 |
